ASB Consultores’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Buy |
462
+107
| +30% | +$56.2K | 0.16% | 120 |
|
|
2025
Q1 | $225K | Sell |
355
-155
| -30% | -$98.3K | 0.15% | 105 |
|
|
2024
Q4 | $363K | Sell |
510
-2
| -0.4% | -$1.43K | 0.15% | 115 |
|
|
2024
Q3 | $538K | Sell |
512
-64
| -11% | -$67.3K | 0.21% | 73 |
|
|
2024
Q2 | $605K | Sell |
576
-224
| -28% | -$235K | 0.22% | 61 |
|
|
2024
Q1 | $770K | Buy |
+800
| New | +$770K | 0.2% | 74 |
|
|
2023
Q4 | – | Sell |
-255
| Closed | -$210K | – | 151 |
|
|
2023
Q3 | $210K | Sell |
255
-146
| -36% | -$120K | 0.08% | 131 |
|
|
2023
Q2 | $288K | Sell |
401
-153
| -28% | -$110K | 0.14% | 137 |
|
|
2023
Q1 | $455K | Buy |
554
+175
| +46% | +$144K | 0.18% | 81 |
|
|
2022
Q4 | $273K | Buy |
+379
| New | +$273K | 0.11% | 141 |
|
|
2022
Q2 | – | Sell |
-360
| Closed | -$251K | – | 223 |
|
|
2022
Q1 | $251K | Buy |
+360
| New | +$251K | 0.11% | 175 |
|